220 related articles for article (PubMed ID: 36462673)
1. European survey on the current surveillance practices, management guidelines, treatment pathways and heterogeneity of testing of Clostridioides difficile, 2018-2019: results from The Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI).
Viprey VF; Granata G; Vendrik KEW; Davis GL; Petrosillo N; Kuijper EJ; Vilken T; Lammens C; Schotsman JJ; Benson AD; Cataldo MA; van der Kooi TII; Wilcox MH; Davies KA;
J Hosp Infect; 2023 Jan; 131():213-220. PubMed ID: 36462673
[TBL] [Abstract][Full Text] [Related]
2. A point-prevalence study on community and inpatient
Viprey VF; Davis GL; Benson AD; Ewin D; Spittal W; Vernon JJ; Rupnik M; Banz A; Allantaz F; Cleuziat P; ; Wilcox MH; Davies KA; ;
Euro Surveill; 2022 Jun; 27(26):. PubMed ID: 35775426
[TBL] [Abstract][Full Text] [Related]
3. Impact of testing on Clostridioides difficile infection in hospitals across Europe: a mathematical model.
Agnew E; Davies KA; Viprey VF; Evans S; Davis GL; Hope R; Wilcox MH; Wingen-Heimann SM; Robotham JV;
Clin Microbiol Infect; 2023 Jun; 29(6):796.e1-796.e6. PubMed ID: 36773769
[TBL] [Abstract][Full Text] [Related]
4. How to: Surveillance of Clostridium difficile infections.
Krutova M; Kinross P; Barbut F; Hajdu A; Wilcox MH; Kuijper EJ;
Clin Microbiol Infect; 2018 May; 24(5):469-475. PubMed ID: 29274463
[TBL] [Abstract][Full Text] [Related]
5. An insight into
Thabit AK; Aljedaani HJ; Alghamdi RH; Badahdah RM; Lashkar MO; Alnajjar A
Expert Rev Gastroenterol Hepatol; 2023; 17(8):805-810. PubMed ID: 37480286
[TBL] [Abstract][Full Text] [Related]
6. European Practice for CDI Treatment.
Fitzpatrick F; Brennan R; van Prehn J; Skally M; Brady M; Burns K; Rooney C; Wilcox MH
Adv Exp Med Biol; 2024; 1435():57-84. PubMed ID: 38175471
[TBL] [Abstract][Full Text] [Related]
7. Community-Associated Clostridioides difficile Infection in Children: A Review of Recent Literature.
Adams DJ; Barone JB; Nylund CM
J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S22-S26. PubMed ID: 34791398
[TBL] [Abstract][Full Text] [Related]
8. Factors Associated with Clostridioides (Clostridium) Difficile Infection and Colonization: Ongoing Prospective Cohort Study in a French University Hospital.
Khanafer N; Vanhems P; Bennia S; Martin-Gaujard G; Juillard L; Rimmelé T; Argaud L; Martin O; Huriaux L; Marcotte G; Hernu R; Floccard B; Cassier P; Group S
Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299978
[No Abstract] [Full Text] [Related]
9. Treatment of Clostridioides difficile Infection and Non-compliance with Treatment Guidelines in Adults in 10 US Geographical Locations, 2013-2015.
Novosad SA; Mu Y; Winston LG; Johnston H; Basiliere E; Olson DM; Farley MM; Revis A; Wilson L; Perlmutter R; Holzbauer SM; Whitten T; Phipps EC; Dumyati GK; Beldavs ZG; Ocampo VLS; Davis CM; Kainer M; Gerding DN; Guh AY
J Gen Intern Med; 2020 Feb; 35(2):412-419. PubMed ID: 31768906
[TBL] [Abstract][Full Text] [Related]
10. [Clostridioides difficile: updated recommendations].
Barbut F; Eckert C; Lalande V; Le Neindre K; Couturier J
Rev Prat; 2022 Sep; 72(7):703-709. PubMed ID: 36511953
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity in practices to reduce the risk of transmission of Clostridioides difficile in healthcare settings: a survey of ESCMID Study Group for Clostridioides difficile (ESGCD) members.
Khanafer NL; Fitzpatrick F; Barbut F; Krutova M; Davies K; Guery B; Vanhems P
Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):785-789. PubMed ID: 38332395
[TBL] [Abstract][Full Text] [Related]
12. Survey of Clostridium difficile infection surveillance systems in Europe, 2011.
Kola A; Wiuff C; Akerlund T; van Benthem BH; Coignard B; Lyytikäinen O; Weitzel-Kage D; Suetens C; Wilcox MH; Kuijper EJ; Gastmeier P;
Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27469420
[TBL] [Abstract][Full Text] [Related]
13. Clostridioides difficile infection in Africa: A narrative review.
Kullin B; Abratt VR; Reid SJ; Riley TV
Anaerobe; 2022 Apr; 74():102549. PubMed ID: 35337974
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
[TBL] [Abstract][Full Text] [Related]
15.
Pujol M; Limón E; Sopena N; Lopez-Contreras J; Castellá L; Cuquet J; López-Sánchez M; Pérez R; Gudiol C; Coloma A; Marimón M; Espinach J; Andres M; Martos P; Hernández S; Almendral A; Saliba P; Rodrigues GC; Calbo E; Group VP
Future Microbiol; 2022 Dec; 17():1445-1453. PubMed ID: 36314417
[No Abstract] [Full Text] [Related]
16. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults.
van Prehn J; Reigadas E; Vogelzang EH; Bouza E; Hristea A; Guery B; Krutova M; Norén T; Allerberger F; Coia JE; Goorhuis A; van Rossen TM; Ooijevaar RE; Burns K; Scharvik Olesen BR; Tschudin-Sutter S; Wilcox MH; Vehreschild MJGT; Fitzpatrick F; Kuijper EJ;
Clin Microbiol Infect; 2021 Dec; 27 Suppl 2():S1-S21. PubMed ID: 34678515
[TBL] [Abstract][Full Text] [Related]
17. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.
Finn E; Andersson FL; Madin-Warburton M
BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040
[TBL] [Abstract][Full Text] [Related]
18. Clostridioides (Clostridium) difficile infection in Japanese hospitals 2008-2017: A real-world nationwide analysis of treatment pattern, incidence and testing density.
Kimura T; Stanhope S; Sugitani T
J Infect Chemother; 2020 May; 26(5):438-443. PubMed ID: 32081648
[TBL] [Abstract][Full Text] [Related]
19. Clostridioides difficile infection (CDI): A pan-European multi-center cost and resource utilization study, results from the Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI).
Wingen-Heimann SM; Davies K; Viprey VF; Davis G; Wilcox MH; Vehreschild MJGT; Lurienne L; Bandinelli PA; Cornely OA; Vilken T; Hopff SM; Vehreschild JJ;
Clin Microbiol Infect; 2023 May; 29(5):651.e1-651.e8. PubMed ID: 36586512
[TBL] [Abstract][Full Text] [Related]
20. A cost-utility analysis of two Clostridioides difficile infection guideline treatment pathways.
Swart N; Sinha AM; Bentley A; Smethurst H; Spencer G; Ceder S; Wilcox MH
Clin Microbiol Infect; 2023 Oct; 29(10):1291-1297. PubMed ID: 37356620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
